BCBA/EMBJ (BCBA/EMBJ)

Buenos Aires Stock Exchange: BCBA/EMBJ · ARS

ARS 119,625

-850.00 (-0.7%)· Recorded snapshot

Market cap	19.8T
Revenue (ttm)	12.6T
Net income (ttm)	666B
EPS (ttm)	ARS 3,714
P/E (trailing)	32.2x
P/E (forward)	19.8x
Dividend	ARS 1,276 (1.07%)
Volume	162

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 12.6T
Net income (ttm): 666B
EPS (ttm): ARS 3,714
P/E (trailing): 32.2x
P/E (forward): 19.8x
Market cap: 19.8T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 13:30 UTC

Forward P/E19.8

P25 n/aP50 n/aP75 n/a

Trailing P/E32.2

P25 n/aP50 n/aP75 n/a

ROE12.2

P25 n/aP50 n/aP75 n/a

ROIC14.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BCBA/EMBJ indicators

Market & fundamental data

Available fields

221

Groups with data

Currency

BRL

Showing 221 of 221 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	Brazil
Country code	AR
Earnings date	2026-11-10
Employees	21,122
Employees change	1,744
Employees growth	9.09%
Enterprise value	ARS 21.1T
Exchange	Buenos Aires Stock Exchange
Financial currency	BRL
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1969
Industry	Aerospace & Defense
Is primary listing	No
ISIN number	ARBCOM460291
Last earnings date	2026-08-10
Last refreshed	2026-10-29
Market cap	ARS 19.8T
Next earnings date	2026-11-10
Price	ARS 119,625.00
Price currency	ARS
Sector	Industrials
SIC code	3721
Stock price date	2026-10-28
Symbol	bcba/EMBJ
Website	https://embraer.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (3Y)	23.78x
Earnings yield	3.1%
EV/Earnings	31.65x
EV/EBIT	18.66x
EV/EBITDA	15.59x
EV/FCF	14.18x
EV/Sales	1.67x
FCF / EV yield	7.05%
FCF yield	7.5%
Forward P/E	19.84x
Graham number	55650.76875
Graham upside	-53.48%
P/B ratio	3.49x
P/E ratio	32.21x
P/FCF ratio	13.33x
P/OCF ratio	11.03x
P/S ratio	1.57x
Price / tangible book value	3.93x
Price/EBITDA ratio	14.57x
Sector P/E	8.95x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	9.01%
EBITDA margin	10.78%
Effective tax rate	17.63%
FCF margin	11.69%
Gross margin	17.85%
Operating margin	9.01%
Pretax margin	6.63%
Profit margin	5.28%
Profit per employee	ARS 31.5M
Profitable quarters	12
Profitable years	3
Revenue per employee	ARS 597.4M
ROA	3.7%
ROA (5Y)	1.7%
ROCE	9.47%
ROE	12.19%
ROE (5Y)	3.41%
ROIC	14.46%
ROIC (5Y)	4.49%
Tax / revenue	1.17%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	10.6%
EPS growth (Q)	113.9%
EPS growth (QoQ)	524.16%
EPS growth 10Y	39.19%
EPS growth quarters	1
EPS growth years	3
FCF growth	19.43%
FCF growth 3Y	80.88%
Gross profit growth	6.57%
Gross profit growth (Q)	12.94%
Gross profit growth 3Y	19.47%
Gross profit growth 5Y	21.46%
Net income growth	8.93%
Net income growth (Q)	141.59%
Net income growth (QoQ)	520.09%
Net income growth quarters	1
Net income growth years	3
OCF growth	12.38%
OCF growth 10Y	14.73%
OCF growth 3Y	52.15%
Operating income growth	5.21%
Operating income growth (Q)	43.76%
Operating income growth 3Y	58.71%
Operating income growth 5Y	58.92%
Revenue growth	10.86%
Revenue growth (Q)	10.37%
Revenue growth (QoQ)	49.45%
Revenue growth 10Y	7.02%
Revenue growth 3Y	20.19%
Revenue growth 5Y	12.69%
Revenue growth quarters	10
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	ARS -309.8B
Depreciation and amortization	ARS 224.5B
EBIT	ARS 1.1T
EBITDA	ARS 1.4T
EPS	ARS 3,713.72
Financing cash flow	ARS 153.8B
Free cash flow	ARS 1.5T
Gross profit	ARS 2.3T
Income taxes	ARS 147.5B
Investing cash flow	ARS -542.7B
Net borrowing	ARS 455.5B
Net cash flow	ARS 1T
Net income	ARS 666B
Operating income	ARS 1.1T
Revenue	ARS 12.6T

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.83
Book value per share	ARS 7,193.35
Debt / EBITDA	2.87
Debt / equity	0.69
Debt / FCF	2.63
Goodwill	ARS 33.4B
Interest coverage	3.42
Long-term assets	ARS 8.6T
Long-term liabilities	ARS 6.3T
Net cash (debt)	ARS -712.3B
Net cash / market cap	-3.59%
Net debt / EBITDA	0.52
Net debt / equity	0.13
Net debt / FCF	0.48
Piotroski F-Score	6
Property, plant and equipment	ARS 3.4T
Shareholders' equity	ARS 5.7T
Tangible book value	ARS 5T
Tangible book value per share	ARS 7,081.20
Total assets	ARS 19.6T
Total cash	ARS 3.2T
Total debt	ARS 3.9T
Total liabilities	ARS 13.9T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.66
Current assets	ARS 11T
Current liabilities	ARS 7.6T
Current ratio	1.44
Inventory turnover	1.87
Net working capital	ARS 432.7B
Quick ratio	0.64
Working capital	ARS 3.3T
Working capital turnover	1,236.68

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.51%
Dividend growth	0%
Dividend growth years	0
Dividend payment date	2027-06-01
Dividend payment years	2
Dividend payout frequency	Quarterly
Dividend per share	ARS 1,276.43
Dividend yield	1.07%
Ex-dividend date	2026-09-23
Last dividend	ARS 249.73
Payout ratio	19.75%
Shareholder yield	2.57%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	ARS 103,982.50
1D price change	-0.71%
1M price change	-5.71%
1M total return	-5.71%
1W price change	0.27%
1W total return	0.27%
1Y price change	27.31%
1Y return CAGR	28.94%
1Y total return	28.92%
20-day SMA	ARS 118,212.50
200-day SMA	ARS 104,184.13
3M price change	9.78%
3M total return	10.01%
3Y price change	898.79%
3Y return CAGR	116.28%
3Y total return	912.29%
50-day SMA	ARS 119,272.00
50-day SMA vs 200-day SMA	50over200
52-week high	ARS 127,175.00
52-week high date	2026-09-25
52-week low	ARS 79,900.00
52-week low date	2026-03-20
6M price change	25.05%
6M total return	25.73%
All-time high	ARS 127,175.00
All-time high date	2026-09-25
All-time low	ARS 985.00
All-time low date	2021-01-29
Average true range (ATR)	ARS 3,537.37
Average volume	1.3K
Change from 52-week high	-5.94%
Change from 52-week low	49.72%
Change from all-time high	-5.8%
Change from all-time low	12,062.44%
Change from open	-1.44%
Day's gap	0.75%
Dollar volume	ARS 19.4M
High price	ARS 121,375.00
Low price	ARS 118,675.00
Monthly RSI	72.01
Open price	ARS 121,375.00
Position in 52-week range	35.19%
Previous close	ARS 120,475.00
Price vs 150-day SMA	15.21%
Price vs 20-day SMA	1.34%
Price vs 200-day SMA	14.99%
Price vs 50-day SMA	0.44%
Relative volume	0.12
RSI	52.29
Sharpe ratio	0.75
Sharpe ratio (3Y)	1.77
Sortino ratio	1.21
Sortino ratio (3Y)	3.12
Volume	162
Weekly RSI	60.4
YTD price change	21.44%
YTD total return	22.1%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	672.1M
Shares change (QoQ)	-0.64%
Shares change (YoY)	-1.51%
Shares held by insiders	0%
Shares held by institutions	67.62%

Deeper analysis on BCBA/EMBJ

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BCBA/EMBJ report

Is a complete BCBA/EMBJ research report available?

No complete published report is available for bcba/EMBJ (BCBA/EMBJ) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/EMBJ (BCBA/EMBJ)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/EMBJ

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/EMBJ indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/EMBJ

Frequently asked questions